 | Articles: Drug Trials |
Cardinal Health Expands Pet Nuclear Pharmacy Services to Support Clinical Drug Trials
Cardinal Health, 06/18/08
Cytokinetics Announces Late Breaking Trials Presentation Relating to CK-1827452 at the 2008 Heart Failure Congress of the European Society of Cardiology
Cytokinetics, 06/18/08
Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy
Corporate News Releases, 06/18/08
 | | Sponsor |
Cytokinetics Provides Updates from Phase I Clinical Trials of CK-1827452
Cytokinetics, 06/17/08
Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Corporate News Releases, 06/17/08
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
Corporate News Releases, 06/17/08
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients With Early Active Rheumatoid Arthritis
Corporate News Releases, 06/16/08
Bristol-Myers and Pfizer initiate new Phase III thromboembolism trial
PharmiWeb, 06/16/08
Array BioPharma Presents Additional Positive Phase 1 Results in Two Programs at the 2008 Annual European Congress of Rheumatology
Array BioPharma, 06/16/08
EpiCept Releases New Ceplene AML Data Demonstrating Leukemia Free Survival as Predictor of Improved Overall Survival
Corporate News Releases, 06/16/08
|
 Receive daily email updates on Drug Trials
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
|
